Maria W Greenwald Selected Research

Knee Osteoarthritis

5/2004

Efficacy and safety of rofecoxib 12.5 mg versus nabumetone 1,000 mg in patients with osteoarthritis of the knee: a randomized controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maria W Greenwald Research Topics

Disease

4	Rheumatoid Arthritis 12/2019 - 09/2006
2	Infections 03/2011 - 09/2006
1	Psoriatic Arthritis 06/2014
1	Pneumonia (Pneumonitis) 03/2011
1	Fatigue 09/2006
1	Chronic Disease (Chronic Diseases) 09/2006
1	Osteoporosis 11/2005
1	Stomatitis 09/2004
1	Hirsutism 09/2004
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 09/2004
1	Acne Vulgaris 09/2004
1	Clinical Deterioration 09/2004
1	Osteoarthritis 05/2004
1	Knee Osteoarthritis 05/2004

Drug/Important Bio-Agent (IBA)

3	Rituximab (Mabthera)FDA Link 05/2014 - 09/2006
2	Methotrexate (Mexate)FDA LinkGeneric 03/2011 - 09/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2011 - 09/2006
1	Janus KinasesIBA 12/2019
1	peficitinibIBA 12/2019
1	Janus Kinase InhibitorsIBA 12/2019
1	Interleukin-17 ReceptorsIBA 06/2014
1	brodalumabIBA 06/2014
1	Monoclonal AntibodiesIBA 06/2014
1	Adalimumab (Humira)FDA Link 03/2011
1	Etanercept (Enbrel)FDA Link 03/2011
1	Tumor Necrosis Factor InhibitorsIBA 03/2011
1	ametantrone (HAQ)IBA 09/2006
1	Hormones (Hormone)IBA 11/2005
1	Dehydroepiandrosterone (DHEA)IBA 09/2004
1	rofecoxib (Vioxx)FDA Link 05/2004
1	Nabumetone FDA LinkGeneric 05/2004

Therapy/Procedure

2	Therapeutics 09/2006 - 09/2004